Literature DB >> 10506529

Sprouting of dopaminergic axons after striatal injury: confirmation by markers not dependent on dopamine metabolism.

G T Liberatore1, D I Finkelstein, J Y Wong, M K Horne, M J Porritt, G A Donnan, D W Howells.   

Abstract

Striatal injury increases dopamine metabolism in the nigrostriatal system but it is unclear whether this response is due to increased synthesis and activation of tyrosine hydroxylase within existing dopamine terminals and/or branching and sprouting of new terminals. While monitoring the density of tyrosine hydroxylase immunoreactive fibers suggests that sprouting occurs, this technique alone cannot adequately answer this question since the intensity of staining and thus the visibility of individual fibers are intimately linked to dopaminergic activity. However, by examining axons and their branches using markers that are independent of dopamine metabolism it is possible to determine whether dopaminergic sprouting does in fact take place. One month after using a Scouten wire knife to create a small lesion in the left striatum of normal C57/bl-6 mice, silver staining revealed an increase in the total number of neuronal fibers throughout the injured striatum. This was accompanied by intense staining of tyrosine hydroxylase-positive fibers around the wound and an increased density of striatal fibers labeled with dextran-biotin after injection of this neuronal tracer into the substantia nigra 1 month after striatal surgery and 5 days prior to sacrifice. The increase in tyrosine hydroxylase immunoreactivity confirms previous observations of increased dopaminergic activity after striatal injury. The increases in silver staining and dextran-biotin transport provide independent evidence that this increase in dopaminergic activity occurs because of sprouting of new fibers originating in the substantia nigra. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10506529     DOI: 10.1006/exnr.1999.7152

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  8 in total

1.  Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson's disease.

Authors:  R Pattarini; R J Smeyne; J I Morgan
Journal:  Neuroscience       Date:  2007-01-29       Impact factor: 3.590

2.  The role of dopamine receptors in regulating the size of axonal arbors.

Authors:  C L Parish; D I Finkelstein; J Drago; E Borrelli; M K Horne
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

3.  Antioxidant effect of Spirulina (Arthrospira) maxima in a neurotoxic model caused by 6-OHDA in the rat striatum.

Authors:  J C Tobón-Velasco; Victoria Palafox-Sánchez; Liliana Mendieta; E García; A Santamaría; G Chamorro-Cevallos; I Daniel Limón
Journal:  J Neural Transm (Vienna)       Date:  2013-02-21       Impact factor: 3.575

4.  The role of interleukin-1, interleukin-6, and glia in inducing growth of neuronal terminal arbors in mice.

Authors:  Clare L Parish; David I Finkelstein; Wanida Tripanichkul; Abhay R Satoskar; John Drago; Malcolm K Horne
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

5.  Heterogeneous intrastriatal pattern of proteins regulating axon growth in normal adult human brain.

Authors:  Junchao Tong; Yoshiaki Furukawa; Allan Sherwin; Oleh Hornykiewicz; Stephen J Kish
Journal:  Neurobiol Dis       Date:  2010-10-26       Impact factor: 5.996

6.  Extended Treatment with Glial Cell Line-Derived Neurotrophic Factor in Parkinson's Disease.

Authors:  Alan L Whone; Mihaela Boca; Matthias Luz; Max Woolley; Lucy Mooney; Sonali Dharia; Jack Broadfoot; David Cronin; Christian Schroers; Neil U Barua; Lara Longpre; C Lynn Barclay; Chris Boiko; Greg A Johnson; H Christian Fibiger; Rob Harrison; Owen Lewis; Gemma Pritchard; Mike Howell; Charlie Irving; David Johnson; Suk Kinch; Christopher Marshall; Andrew D Lawrence; Stephan Blinder; Vesna Sossi; A Jon Stoessl; Paul Skinner; Erich Mohr; Steven S Gill
Journal:  J Parkinsons Dis       Date:  2019       Impact factor: 5.568

7.  Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson's disease.

Authors:  Alan Whone; Matthias Luz; Mihaela Boca; Max Woolley; Lucy Mooney; Sonali Dharia; Jack Broadfoot; David Cronin; Christian Schroers; Neil U Barua; Lara Longpre; C Lynn Barclay; Chris Boiko; Greg A Johnson; H Christian Fibiger; Rob Harrison; Owen Lewis; Gemma Pritchard; Mike Howell; Charlie Irving; David Johnson; Suk Kinch; Christopher Marshall; Andrew D Lawrence; Stephan Blinder; Vesna Sossi; A Jon Stoessl; Paul Skinner; Erich Mohr; Steven S Gill
Journal:  Brain       Date:  2019-03-01       Impact factor: 13.501

Review 8.  Exercise-Induced Neuroprotection of the Nigrostriatal Dopamine System in Parkinson's Disease.

Authors:  Lijuan Hou; Wei Chen; Xiaoli Liu; Decai Qiao; Fu-Ming Zhou
Journal:  Front Aging Neurosci       Date:  2017-11-03       Impact factor: 5.750

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.